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08.013September 18, 2013, marks 2 years since the monu-
mental meeting of Heads of State at the United Nations in
New York to take action against noncommunicable dis-
eases (NCDs), which includes cancer, cardiovascular dis-
ease (CVD), diabetes mellitus, and chronic respiratory
disease. Recognizing that the rising human and ﬁnancial
costs of NCDs required a profound shift in the way
countries viewed development, United Nations member
states gathered for the second time in history to address a
health concern (the ﬁrst being the United Nations General
Assembly Special Session on HIV/AIDS in 2001). Sup-
porting the United Nations Political Declaration on the
Prevention and Control of NCDs, countries acknowledged
NCDs as a development issue and made a commitment to
address this global crisis by taking action on the major
modiﬁable risk factors—including tobacco use, raised
blood pressure, poor nutrition, physical inactivity—
triggering the new pandemic of NCDs, as well as the social,
economic, and political determinants that shape these
lifestyle choices [1]. Although the declaration was a polit-
ical commitment, it was an important ﬁrst step, bringing
together health and development leaders from across the
globe to ensure that progress would be made to reduce the
burden of NCDs. The past 2 years have witnessed concrete
commitments, meaning that our work is only just
beginning.
The World Heart Federation and its members
spearheaded global advocacy, with other colleagues in the
NCD community, calling on the World Health Organi-
zation and member states to commit to tangible and
achievable goals [2]. In 2012, a global target was adopted
to reduce premature NCD mortality 25% by 2025—
“25by25” [3]. Now in 2013, this target, as well as 8
additional targets addressing modiﬁable risk factors and
committing to the use of essential medicines, technolo-
gies, and drug therapies to prevent heart attacks and
strokes, have been adopted as part of a global monitoring
framework and included in the World Health Organiza-
tion’s Global Action Plan for the Prevention and Control
of NCDs (see online-only Appendix for a list of the
globally agreed targets and indicators) [4,5].
These collective decisions taken by governments and
ministers of health have ensured that a global architecture
is in place that requires governments to be accountable
for the actions they take to address NCDs in theirGLOBAL HEART, VOL. 8, NO. 4, 2013
December 2013: 383-386countries. This is an extraordinary time of opportunity
for the CVD community. As we move from political
aspiration to practical application, what role can the CVD
community play in developing and implementing a co-
ordinated international strategy of action to attain these
fundamental goals for the health of nations?
At the global level, the adoption of this architecture—a
global monitoring framework with 9 ambitious targets
and 25 indicators—means that governments, for the ﬁrst
time, are accountable for progress on NCDs. These
commitments will be translated into action at the national
level through strong and cost-effective national plans.
Each of our professional organizations will advocate for
and offer solutions that can be implemented nationally to
address these targets. Systems change is not limited to
systems that address health. As the world develops a
framework to eradicate poverty and to reassesses the
Millennium Development Goals, further progress will
depend on recognizing that determinants outside health
services affect the health of populations and patients.
How people live, move, work, and eat is of paramount
importance, and interventions to reduce exposure to
modiﬁable risk factors, as well as address the underlying
social determinants, must be planned and implemented
now to protect future generations.
The changes we are seeing in models of care in
high-income countries toward controlling upstream de-
terminants of NCDs must be expanded. Even the most
advanced healthcare systems need to improve how they
address primordial and primary prevention through
change in population behavior across the life span.
Acknowledging that health systems in low- and middle-
income countries have been built around infectious
disease, these systems must now transform to address
CVD morbidity and mortality. Tackling the growing
burden of NCDs requires not only a whole of govern-
ment approach but also a whole of society approach
involving nongovernmental organizations, local commu-
nities, and industry, where appropriate. The CVD civil
society community of heart and stroke foundations and
societies across the globe must have a leading role in
the implementation of national NCD plans and ensure
a focus on CVD primordial, primary, and secondary
prevention and rehabilitation. Sharing best practices,
aligning measurements, fostering expertise, advancing383
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FIGURE 1. Reducing cardiovascular disease through a World Heart Federation global target of 25% by 2025 [6]. CVD
indicates cardiovascular disease; NCDs, noncommunicable diseases; and WHF, World Heart Federation.
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critical and feasible measures to ensure that we achieve
the “25by25” target, not only for NCDs, but for CVD as
well (Figure 1 [6]).
The Global Cardiovascular Disease Taskforce—
comprising the World Heart Federation, American Heart
Association, American College of Cardiology Foundation,
European Heart Network, and European Society of Car-
diology, and expanded representation from Asia, Africa,
and Latin America along with global CVD experts—is
helping to sharpen our collective efforts to address CVDs.
Working with the World Health Organization, we are
assessing and deﬁning those speciﬁc metrics for
addressing CVD that will be key to achieving the global
target of “25by25.” These metrics will extend beyond
health systems and will be essential to preventing pre-
mature mortality. As CVD organizations operating with
and through the World Heart Federation, which itself
represents >200 organizations across the globe, and as
partners to the World Health Organization, we are
committed to the following:1. Developing and publishing metrics around the
“25by25” target that are speciﬁc to CVD and
tailored by geography by 2014.
2. Shaping and supporting inclusion of CVD lan-
guage in national plans.
3. Coordinating and aligning efforts around
implementation of the CVD-related targets un-
der the “25by25” global target, with a particular
focus on reducing tobacco use and hyperten-
sion and improving secondary prevention and
rehabilitation of CVD.As we move forward together as professional societies
and heart foundations, let us be the global advocates,
speaking with one voice, calling for CVD prevention, treat-
ment, and care. We celebrate the Political Declaration of
“25by25” and its aspiration to reduce the burden of NCDs,
and we now face the challenges of ensuring its reality and
ensuring that government plans turn to action to improve
the health of all of our populations.GLOBAL HEART, VOL. 8, NO. 4, 2013
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